Drug Profile
Research programme: engineered T cells - Cell Design Labs
Alternative Names: CellBot™ therapy; synNotch™ T-cellsLatest Information Update: 22 Sep 2023
Price :
$50
*
At a glance
- Originator Cell Design Labs
- Class CAR-T cell therapies; Immunotherapies; T lymphocyte cell therapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer
Most Recent Events
- 22 Sep 2023 Discontinued - Preclinical for Autoimmune disorders in USA (Parenteral)
- 22 Sep 2023 Discontinued - Preclinical for Cancer in USA (Parenteral)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (Parenteral)